## LDOS: Leidos Holdings, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -4.2% below STRENGTH zone (4.0-10.0%); PEG 2.34 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($176.42)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.00M) |
| Sells | 4 ($0.03M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (-0.7%)
- Blackrock Inc.: 8.5% (-3.6%)
- JPMORGAN CHASE & CO: 5.3% (+93.7%)
- State Street Corpora: 4.5% (+1.4%)
- FMR, LLC: 2.9% (+31.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.34 elevated, pricing in significant growth expectations. Forward P/E 15.1x stretched relative to 4% growth. Quality metrics strong (ROE 29%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $23.8B |
| Beta | 0.59 |
| 52W Range | $123.62 - $205.77 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.34 |
| Forward P/E | 15.1 |
| Current P/E | 15.7 |
| YoY Growth | 4.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -4.2% (minimal 5-day change). Below STRENGTH zone by 8.2pp (needs >4.0% for momentum thesis). Underperforming sector by 5.4pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.13x) but short-term weakness (below SMA20). RSI neutral at 43.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.25% (CS: 21) | Weak |
| RSI_14 | 43.0 | Neutral |
| MACD Histogram | -0.37 | Bearish |
| vs SMA20 | 0.977x | Below |
| vs SMA50 | 0.973x | Below |
| vs SMA200 | 1.127x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $185.62
- **Stop Loss:** $176.42 (5.0% risk)
- **Target:** $194.82 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 130
- **Position Value:** $24,130.60
- **Portfolio %:** 24.13%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-02-17 (Est: $2.58)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.72 | $3.05 | +12.3% |
| 2025Q2 | $2.66 | $3.21 | +20.8% |
| 2025Q1 | $2.50 | $2.97 | +18.7% |
| 2024Q4 | $2.27 | $2.37 | +4.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*